Entero Healthcare Directors' Reappointment Tenure Revised

Entero Healthcare Solutions Ltd announced a revision in the reappointment tenure for Non-Executive Independent Directors Mr. Rajesh Shashikant Dalal and Ms. Sandhya Gadkari Sharma. This change, approved by the Board of Directors based on the Nomination and Remuneration Committee's recommendation, aims to facilitate effective succession planning and smoother board transitions. The revised tenure is subject to shareholder approval at the upcoming Annual General Meeting. Additionally, the company approved the allotment of 1,475 equity shares under its ESOP 2023 plan.